Jonathan E. Lim - 14 Dec 2022 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role: Chairman & CEO, Director, 10%+ Owner
Signature: /s/ Ebun Garner, attorney-in-fact
Issuer symbol: ERAS
Transactions as of: 14 Dec 2022
Net transactions value: +$199,600
Form type: 4
Filing time: 15 Dec 2022, 10:53:55 UTC
Previous filing: 03 Feb 2022
Next filing: 15 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERAS	Common Stock	Purchase	$199,600	+40,000	+0.2%	$4.99	20,196,222	14 Dec 2022	By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005	F1
holding	ERAS	Common Stock						11,899,360	14 Dec 2022	By City Hill, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F2	Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.

Content

The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.

Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.